Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Borderline tumors of the ovary and peritoneal implants.

Borderline tumors of the ovary and peritoneal implants. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Borderline tumors of the ovary and peritoneal implants. Abstract Text:

    c denkertC Denkert,m dietelM Dietel,c denkertC Denkert,m dietelM Dietel,

    The new WHO series on Pathology and Genetics of Tumours of the Breast and Female Genital Organs (33) defined to name the group of epithelial ovarian tumors with a dignity between benign and malignant exclusively as Borderline Tumors of the Ovary (BOT) and to skip the term "... of low malignant potential". Further, the term "atypical proliferative tumour" was not recommended by the WHO. During a Consensus Meeting on Borderline Tumors of the Ovary held at Bethesda on August 27-28, 2003 (2) the expert panel also recommended to use the BOT terminology. However the term "tumour of low malignant potential" and--less favourable--"atypical proliferative tumour" may be used as synonym. Both groups agreed unanimously that the name carcinoma should not be included in the diagnosis. The group of borderline ovarian tumors is heterogeneous. 80 to 90% of the cases have a very favourable prognosis while 10-20% exhibit a recurrent clinical course with peritoneal implants and very rarely death from the tumor within 10 years. The morphological criteria and supporting methods for recognizing unfavorable BOT and for distinguishing them from highly differentiated ovarian carcinomas are summarized. The prognostic importance of peritoneal implants is described. The concept of micropapillary serous carcinomas (MPSC) and its implications on the diagnostic work of pathologists will be discussed. The presented data focus on serous tumors since this is by far the most common variant.

    Borderline tumors of the ovary and peritoneal implants. Publishing Authors By Initials

    c denkertC Denkert,m dietelM Dietel,c denkertC Denkert,m dietelM Dietel,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Borderline tumors of the ovary and peritoneal implants. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Verhandlungen der Deutschen Gesellschaft für Patho

    VOLUME: 89

    Page Numbers: 84-91

    Journal Abbreviation:

    ISSN: 0070-4113

    DAY: 26

    MONTH: 11

    YEAR: 2005

    Borderline tumors of the ovary and peritoneal implants. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7503704

    Borderline tumors of the ovary and peritoneal implants. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Borderline tumors of the ovary and peritoneal implants. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Borderline tumors of the ovary and peritoneal implants.

    AFFILIATION: Institute of Pathology, Charité Hospital, Humboldt-University Berlin, Schumannstrasse 20-21, D-10117 Berlin, Germany.

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Verh Dtsch Ges Pathol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Borderline tumors of the ovary and peritoneal implants Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News